NDC 0517-2502-01 - Caffeine and Sodium Benzoate
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0517-2502
- Requested NDC
- 0517-2502-01
- Package NDCs from labels
- 0517-2502-01, 0517-2502-10
- Manufacturer
- American Regent, Inc.
- Effective date
- 2019-12-06
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| CAFFEINE AND SODIUM BENZOATE INJECTION, USP | American Regent, Inc. | 2019-12-06 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0517-2502-01 | Caffeine and Sodium Benzoate | 2 mL in 1 VIAL, SINGLE-DOSE | INJECTION, SOLUTION | 2 | 7 | |
| 0517-2502-10 | Caffeine and Sodium Benzoate | 10 in 1 BOX | INJECTION, SOLUTION | 10 | 7 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0517-2502-01 | ML - Milliliter | 0517-2502 | d7f8e535-ca10-4ba1-a0b6-b855c1d92936 | 1 | 2019-04-11 |
| 0517-2502-10 | ML - Milliliter | 0517-2502 | d29437c4-d880-4d96-8542-9b17a6fc2fc0 | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| CAFFEINE | ACTIVE INGREDIENT | 3G6A5W338E | CAFFEINE AND SODIUM BENZOATE INJECTION, SOLUTION [AMERICAN REGENT, INC.] | 1 | |
| CAFFEINE | ACTIVE MOIETY | 3G6A5W338E | CAFFEINE AND SODIUM BENZOATE INJECTION, SOLUTION [AMERICAN REGENT, INC.] | 1 | |
| HYDROCHLORIC ACID | INACTIVE INGREDIENT | QTT17582CB | CAFFEINE AND SODIUM BENZOATE INJECTION, SOLUTION [AMERICAN REGENT, INC.] | 1 | |
| SODIUM BENZOATE | INACTIVE INGREDIENT | OJ245FE5EU | CAFFEINE AND SODIUM BENZOATE INJECTION, SOLUTION [AMERICAN REGENT, INC.] | 1 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | CAFFEINE AND SODIUM BENZOATE INJECTION, SOLUTION [AMERICAN REGENT, INC.] | 1 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | CAFFEINE AND SODIUM BENZOATE INJECTION, SOLUTION [AMERICAN REGENT, INC.] | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Tension Headache Relief | ACETAMINOPHEN, CAFFEINE | NUVICARE LLC | ea4e50e9-2c4d-4e58-b2cb-ab23e91fd50e | 2025-12-19 | Warnings | 3G6A5W338E |
| Acetaminophen, Aspirin and Caffeine | ACETAMINOPHEN, ASPIRIN AND CAFFEINE | Safeway, Inc | f2a2cbb5-5a63-7514-e053-2995a90a572c | 2025-12-19 | Warnings | 3G6A5W338E |
| Acetaminophen Aspirin Caffeine | ACETAMINOPHEN ASPIRIN CAFFEINE | CVS PHARMACY, INC | c340c5ef-e15d-53ce-e053-2995a90a73e7 | 2025-12-19 | Warnings | 3G6A5W338E |
| Acetaminophen Aspirin Caffeine | ACETAMINOPHEN ASPIRIN CAFFEINE | WALGREEN CO | c32c8cbd-5775-afe3-e053-2995a90a81cb | 2025-12-19 | Warnings | 3G6A5W338E |
| Acetaminophen, Aspirin and Caffeine | ACETAMINOPHEN, ASPIRIN AND CAFFEINE | FAMILY DOLLAR | f837e190-6fb3-e22e-e053-6394a90a12e6 | 2025-12-19 | Warnings | 3G6A5W338E |
| Nuvicare Headache Relief | ACETAMINOPHEN, ASPIRIN, CAFFEINE | NUVICARE LLC | 3ede0fb6-c089-4253-9878-2b01c39e9c87 | 2025-12-19 | Warnings | 3G6A5W338E |
| Sterile Water | WATER | ProPharma Distribution | 386a0a2f-4ff7-f128-e063-6294a90a7d4d | 2025-12-18 | Warnings, Adverse reactions | 059QF0KO0R |
| Hemorrhoid | AESCULUS HIPP, HAMAMELIS, ALOE, CALC PHOS, CARBO AN, CARBO VEG, LACHESIS, LYCOPODIUM, MURIATICUM AC, NITRICUM AC, NUX VOM, PAEONIA, RATANHIA, SEPIA, SULPHUR | Natural Creations, Inc | db1b3aef-ba92-417c-b6f6-58e950ed4214 | 2025-12-16 | Warnings | QTT17582CB |
| Vanquish Extra Strength | ACETAMINOPHEN, ASPIRIN, AND CAFFEINE | DSE Healthcare Solutions, LLC | cbf12223-ef44-494b-9d3c-971dce3c5ade | 2025-12-15 | Warnings | 3G6A5W338E |
| Menstrual Complete | ACETAMINOPHEN, CAFFEINE, PYRILAMINE MALEATE | WinCo Foods, LLC | 860c4e94-1d1a-4f74-a14a-35f86f4523c4 | 2025-12-11 | Warnings | 3G6A5W338E |
| Stay Awake | CAFFEINE | VALU MERCHANDISERS COMPANY | b2ae7941-5711-4046-b715-bc77cc04becb | 2025-12-11 | Warnings | 3G6A5W338E |
| Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate | BUTALBITAL, ACETAMINOPHEN, CAFFEINE, AND CODEINE PHOSPHATE | Actavis Pharma, Inc. | 52321fe5-c001-4e2d-8149-3197ddc13764 | 2025-12-10 | Boxed warning, Warnings, Adverse reactions | 3G6A5W338E |
| Midol Complete, Travel BASIX | ACETAMINOPHEN, CAFFEINE, AND PYRILAMINE MALEATE | Lil' Drug Store Products, Inc | d6d47af8-5f8c-4c8c-a8c6-aa214ec23bca | 2025-12-10 | Warnings | 3G6A5W338E |
| BUTALBITAL, ACETAMINOPHEN AND CAFFEINE | BUTALBITAL, ACETAMINOPHEN AND CAFFEINE | Advanced Rx of Tennessee, LLC | 45a18fad-ad4e-3a1b-e063-6394a90a23cf | 2025-12-10 | Boxed warning, Warnings, Adverse reactions | 3G6A5W338E |
| Butalbital, Acetaminophen, and Caffeine | BUTALBITAL, ACETAMINOPHEN, AND CAFFEINE | Actavis Pharma, Inc. | ea5b9ffe-3cda-405e-8f75-3fd4a64c9a35 | 2025-12-10 | Boxed warning, Warnings, Adverse reactions | 3G6A5W338E |
| Fioricet | BUTALBITAL, ACETAMINOPHEN, AND CAFFEINE | Actavis Pharma, Inc. | c018be7d-f7b8-45e2-97b8-8e7a71740657 | 2025-12-10 | Boxed warning, Warnings, Adverse reactions | 3G6A5W338E |
| Firstep Firstflush | EYEWASH | Encon Safety Products, Inc. | a44beb26-79ae-98bd-e053-2995a90a9b74 | 2025-12-09 | Warnings | 059QF0KO0R |
| Menstrual Pain Relief Complete | ACETAMINOPHEN, PYRILAMINE MALEATE, CAFFEINE | Shield Pharmaceuticals Corp | 5efd6c61-74ed-4253-896a-e4a40bd8f25b | 2025-12-09 | Warnings | 3G6A5W338E |
| BUTALBITAL, ACETAMINOPHEN AND CAFFEINE | BUTALBITAL, ACETAMINOPHEN AND CAFFEINE | Chartwell RX, LLC | 77776146-c6e6-478c-b30e-2b729e758400 | 2025-12-09 | Boxed warning, Warnings, Adverse reactions | 3G6A5W338E |
| Excedrin Extra Strength, TRAVEL BASIX | ACETAMINOPHEN, ASPIRIN, AND CAFFEINE | Lil Drug Store Products, Inc | 7f0f8b3c-c226-4a3a-af46-a708f345e4f5 | 2025-12-09 | Warnings | 3G6A5W338E |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.